Zobrazeno 1 - 10
of 811
pro vyhledávání: '"I. A. Li"'
Autor:
O. V. Knyazev, A. V. Kagramanova, A. A. Lishchinskaya, A. F. Babaian, T. V. Shkurko, B. A. Nanaeva, I. A. Li
Publikováno v:
Медицинский совет, Vol 0, Iss 14, Pp 96-106 (2022)
Introduction. According to clinical guidelines, the treatment of patients with ulcerative colitis (UC) is carried out as combination therapy with mesalazine in rectal forms.The aim was to compare the effectiveness of treatment of moderate severity UC
Externí odkaz:
https://doaj.org/article/f212816e7d5847a8a36a01ebd2d83fa8
Autor:
O. V. Knyazev, A. V. Kagramanova, A. A. Lishchinskaya, I. A. Li, D. V. Podolskaya, T. V. Shkurko, B. A. Nanaeva, T. L. Aleksandrov, T. A. Baranova, I. A. Tishaeva, M. Yu. Zvyaglova, A. I. Parfenov
Publikováno v:
Медицинский совет, Vol 0, Iss 15, Pp 20-29 (2021)
Introduction. Tofacitinib is the first member of a new class of targeted synthetic anti-inflammatory drugs for the treatment of ulcerative colitis (UC). The article presents a three-year Russian experience of tofacitinib use for the treatment of mode
Externí odkaz:
https://doaj.org/article/f0ccd53b02d34cefa5b317533f978e88
Autor:
O. V. Knyazev, M. Yu. Zvyaglova, A. V. Kagramanova, I. A. Li, E. A. Sabelnikova, A. A. Lishchinskaya, D. S. Kulakov, A. I. Parfenov
Publikováno v:
Терапевтический архив, Vol 93, Iss 2, Pp 150-157 (2021)
Aim. To define the frequency of adverse events and loss of the response in patients with ulcerative colitis (UC) and Crohns disease (CD), treated with original medicine infliximab (IFX) Remicaide and its biosimilars. Materials and methods. We incl
Externí odkaz:
https://doaj.org/article/7b2a05de304e4187a8a9f0dd6dd2c75c
Autor:
Li‑Ting Kao, Hui‑Wen Yang, Yu‑Tien Chang, I‑Hsun Li, Liang‑Hsuan Chen, Ya‑Chiao Hu, Yi‑Hsien Chen
Publikováno v:
Dermatologica Sinica; Apr-Jun2024, Vol. 42 Issue 2, p110-119, 10p
Publikováno v:
Patient Preference and Adherence. 17:769-780
Publikováno v:
IEEE Sensors Journal. 23:1671-1682
Autor:
Hesong Han, Albert Vallejo Gracia, Joachim J. Røise, Lydia Boike, Kristoffer Leon, Ursula Schulze-Gahmen, Michael R. Stentzel, Teena Bajaj, Dake Chen, I.-Che Li, Maomao He, Kamyar Behrouzi, Zahra Khodabakhshi, Daniel K. Nomura, Mohammad R. K. Mofrad, G. Renuka Kumar, Melanie Ott, Niren Murthy
Publikováno v:
RSC advances, vol 13, iss 16
Covalent inhibitors of the papain-like protease (PLpro) from SARS-CoV-2 have great potential as antivirals, but their non-specific reactivity with thiols has limited their development. In this report, we performed an 8000 molecule electrophile screen
Autor:
Mandy C Chen, Hsiao-Wen Chen, Michael Rauch, Zhijie Qu, Sean D Johnson, Jennifer I-Hsiu Li, Joop Schaye, Gwen C Rudie, Fakhri S Zahedy, Erin Boettcher, Kathy L Cooksey, Sebastiano Cantalupo
Publikováno v:
Monthly Notices of the Royal Astronomical Society. 518:2354-2372
We present the first empirical constraints on the turbulent velocity field of the diffuse circumgalactic medium around four luminous QSOs at $z\!\approx\!0.5$--1.1. Spatially extended nebulae of $\approx\!50$--100 physical kpc in diameter centered on
Association Between Volume and Outcomes of Infective Endocarditis Surgery: A Nationwide Cohort Study
Autor:
Kuo-Sheng Liu, Hsiu-An Lee, Victor Chien-Chia Wu, Chia-Pin Lin, Pao-Hsien Chu, Yi-Hsin Chan, I-Hsien Li, An-Hsun Chou, Yu-Ting Cheng, Shao-Wei Chen, Shang-Hung Chang
Publikováno v:
The Annals of Thoracic Surgery. 114:1695-1704
Background To determine the relationship between hospital surgical volume and mortality risk and valve repair rate in infective endocarditis (IE) surgery. Methods Using the Taiwan National Health Insurance Research Database (NHIRD), 3873 patients wer
Autor:
O. V. Knyazev, A. V. Kagramanova, A. А. Lischinskaya, I. А. Li, E. А. Sabelnikova, A. N. Demchenko, B. А. Nanaeva, E. Yu. Zhulina, N. V. Kamzarakova, M. V. Chebotareva, N. А. Fadeeva, K. А. Nikolskaya
Publikováno v:
Meditsinskiy sovet = Medical Council. :105-116
Introduction.The results of registrational clinical trials (CTs) and real clinical practice do not always correlate. The task of practitioners is to find optimal approaches to the therapy of Crohn’s disease, based on the analysis of clinical trials